Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations

Journal article

Nakahashi H. et al, (2024), Journal of Oncology, 2024, 1 - 12

Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment

Journal article

Ma J. et al, (2024), Proceedings of the National Academy of Sciences, 121

DNA damage remodels the MITF interactome to increase melanoma genomic instability

Journal article

Binet R. et al, (2024), Genes & Development, 38, 70 - 94

Single-cell profiling of MC1R-inhibited melanocytes.

Journal article

Berns HM. et al, (2023), Pigment cell & melanoma research

TFE3 promotes ferroptosis in melanoma.

Journal article

Dias D. et al, (2023), Pigment cell & melanoma research

Acetylation reprograms MITF target selectivity and residence time

Journal article

Louphrasitthiphol P. et al, (2023), Nature Communications, 14

Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer: 18 F-labeled rBC2LCN lectin.

Journal article

Kuroda Y. et al, (2023), Cancer science, 114, 3364 - 3373

Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer.

Journal article

Kuroda Y. et al, (2023), International journal of cancer, 152, 1425 - 1437

Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy.

Journal article

Yang Y. et al, (2022), Gastric Cancer, 25, 896 - 905

TBX2 controls a proproliferative gene expression program in melanoma.

Journal article

Lu S. et al, (2021), Genes & development, 35, 1657 - 1677

ETS factors are required but not sufficient for specific patterns of enhancer activity in different endothelial subtypes

Journal article

Neal A. et al, (2021), Developmental Biology, 473, 1 - 14

Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution

Journal article

Louphrasitthiphol P. et al, (2020), Molecular Cell, 79, 472 - 487.e10

ABCB5is activated by MITF and β‐catenin and is associated with melanoma differentiation

Journal article

Louphrasitthiphol P. et al, (2020), Pigment Cell & Melanoma Research, 33, 112 - 118

Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.

Journal article

Vivas-García Y. et al, (2020), Molecular cell, 77, 120 - 137.e9

The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor

Journal article

Coe EA. et al, (2019), PLOS Genetics, 15, e1008501 - e1008501

MITF controls the TCA cycle to modulate the melanoma hypoxia response.

Journal article

Louphrasitthiphol P. et al, (2019), Pigment cell & melanoma research, 32, 792 - 808

BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.

Journal article

Herbert K. et al, (2019), Genes & development, 33, 310 - 332

Venous identity requires BMP signalling through ALK3

Journal article

Neal A. et al, (2019), Nature Communications, 10

Macrophage Cytoplasmic Transfer in Melanoma Invasion

Journal article

Louphrasitthiphol P. and Goding CR., (2017), Developmental Cell, 43, 543 - 544

In this section